Psyence Biomedical (PBM) Stock Research

Psyence Biomedical

· PBM

Dashboard

Financials

Ratios

Valuation

Statistics

20.712 M

+0.55%

Monday

Psyence Biomedical announces exclusive U.S. Ibogaine license for TIRC

Sep 28, 7:06 AM

Thursday

Psychedelic: Optimi completes psilocybin production for Phase 2 trial

Sep 24, 10:27 AM

Over a week ago

Psyence Biomedical announces strategic Ibogaine investment

Sep 23, 7:13 AM

Psychedelic: Definium's LSD-based drug meets endpoints in GAD study

Sep 17, 9:51 AM

Psyence Biomedical establishes Texas Ibogaine Research Corporation

Sep 14, 7:08 AM

Psyence Biomedical files to sell 1.15M common shares for holders

Aug 26, 6:06 AM

Psyence Biomedical announces U.S. engagement initiative focused on ibogaine

May 15, 9:21 AM

What You Missed On Wall Street On Monday

+33

Apr 20, 4:21 PM

Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia

+34

Apr 20, 11:53 AM

Psyence Biomedical provides update on position in global ibogaine market

Apr 20, 8:04 AM

Psyence Biomedical Ltd trading resumes

Apr 17, 3:11 PM

Psyence Biomedical Ltd trading halted, volatility trading pause

Apr 17, 3:06 PM

Trump Trade: President to sign order on psychedelic used for PTSD

Apr 17, 9:53 AM

Psyence acknowledges reports on U.S. action to advance Ibogaine research

Apr 17, 9:22 AM

Trump to sign order on psychedelic used for PTSD, CBS News says

Apr 16, 12:04 PM

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

Apr 9, 10:57 AM

Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results

Mar 5, 10:14 AM

Psyence Biomedical announces export of psilocybin to Australia

Mar 3, 9:16 AM

Psyence Biomedical announces results of annual, special meeting

Feb 17, 9:20 AM

Psyence Biomedical board approves put option agreement with PsyLabs

Feb 13, 6:31 PM

Psychedelic: Clearmind reports additional CMND-100 safety results

Feb 12, 10:35 AM

Psyence Biomedical announces settlement of shareholder litigation

Feb 11, 9:17 AM

Psyence Biomedical Ltd trading halted, news pending

Jan 30, 7:50 PM

Psychedelic: Analyst raises Compass, Definium, GH Research price targets

Jan 29, 10:26 AM

Psychedelic: Analyst initiates Atai Beckley with Buy rating

Jan 22, 11:30 AM

Charts